SafriCanna

Legal

Compliance notice

Intended audience

This website is intended for licensed businesses, healthcare professionals, regulators, prospective counterparties and prospective investors. It is not intended for patients or the general public, and it is not a source of information about treatment.

Where the site contains technical product information, that information is withheld behind a declaration of licensed or professional capacity, and is released only under confidentiality.

Not promotional material for a medicine

Medical cannabis is a prescription medicine in the markets SafriCanna supplies. The advertising of prescription medicines to the general public is prohibited — in South Africa under the Medicines and Related Substances Act and SAHPRA's requirements, and in the European Union under Article 88 of Directive 2001/83/EC.

This website therefore describes SafriCanna's manufacturing capability, quality system and certification status. It does not promote a medicinal product, does not name indications, and does not make therapeutic, efficacy, comparative or safety claims.

No medical advice

Nothing on this website is medical advice. Decisions about treatment are for a qualified healthcare professional in the patient's own jurisdiction. Patients should not contact SafriCanna for product, prescriptions or clinical guidance.

No offer to supply

Nothing on this website constitutes an offer, invitation or solicitation to supply any product. Supply takes place only under contract, only to entities holding the authorisations their jurisdiction requires, and only where lawful in both the exporting and importing jurisdiction.

Claims and substantiation

Certification and licensing statements are made with their scope and holder identified, and are supported by current certificates that are provided to counterparties on request. Certificate scope changes over time, which is why certificates are not published as static copies on this site.

Investor information

Material relating to investment, corporate transactions or acquisitions is not published on this website. It is held in a private, access-controlled document room and released only to authorised directors and accredited investors. Nothing on the public site is an offer of securities or investment advice.